Related Experiment Video

Updated: Jul 9, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity

Ian M Copple1, Christopher E Goldring, Neil R Kitteringham

  • 1The Department of Pharmacology and Therapeutics, The University of Liverpool, Liverpool, Merseyside L69 3GE, UK.

Toxicology
|December 18, 2007
PubMed

Insights

The Nrf2 defense pathway protects cells from toxic insults. Animals lacking Nrf2 (Nuclear factor erythroid 2-related factor 2) show increased vulnerability to drug-induced toxicity.

Area of Science:

  • Biochemistry
  • Toxicology
  • Molecular Biology

Background:

  • Metabolic biotransformation of xenobiotics can cause oxidative stress and adverse drug reactions.
  • Mammalian cells possess defense systems against chemical and oxidative stresses.
  • Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates cytoprotective genes, crucial for cellular survival against toxins.

Purpose of the Study:

  • To review the biochemistry of the Nrf2 defense pathway.
  • To highlight Nrf2's role in protecting against drug-induced toxicity.
  • To examine evidence of increased toxin vulnerability in Nrf2-deficient animals.

Main Methods:

  • Review of current scientific literature.
  • Examination of investigations on Nrf2-deficient animal models.
  • Analysis of Nrf2's role in regulating cytoprotective genes.

Main Results:

  • Nrf2 is a critical determinant of cellular survival following toxic insults.
  • Nrf2-deficient animals exhibit heightened susceptibility to various toxins.
  • The Nrf2 pathway is fundamental to cellular defense mechanisms.

Conclusions:

  • The Nrf2 pathway is essential for mitigating drug-induced toxicity.
  • Understanding Nrf2 biochemistry is key to developing strategies against xenobiotic toxicity.
  • Nrf2 plays a vital role in cellular protection against chemical and oxidative stress.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...